Korro Bio Files 8-K
Ticker: KRRO · Form: 8-K · Filed: Nov 4, 2024 · CIK: 1703647
| Field | Detail |
|---|---|
| Company | Korro Bio, Inc. (KRRO) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing
TL;DR
Korro Bio filed an 8-K on Nov 4, 2024. No major news yet, just a filing.
AI Summary
Korro Bio, Inc. filed an 8-K on November 4, 2024, to report other events and financial statements. The company, formerly known as Frequency Therapeutics, Inc. until April 12, 2017, is incorporated in Delaware and headquartered in Cambridge, MA. This filing does not contain specific financial figures or details about the 'other events' beyond its classification.
Why It Matters
This 8-K filing indicates that Korro Bio, Inc. has made a regulatory submission to the SEC, which could contain important updates about the company's operations or financial status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K and does not disclose any new material risks or adverse information.
Key Players & Entities
- Korro Bio, Inc. (company) — Registrant
- Frequency Therapeutics, Inc. (company) — Former company name
- November 4, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Cambridge, MA (location) — Principal executive offices
- 60 First Street, 2nd floor, Suite 250 (address) — Business address
- 617-468-1999 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by Korro Bio, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
When was Korro Bio, Inc. formerly known as Frequency Therapeutics, Inc.?
Korro Bio, Inc. was formerly known as Frequency Therapeutics, Inc. as of April 12, 2017.
What is the principal executive office address for Korro Bio, Inc.?
The principal executive offices are located at 60 First Street, 2nd floor, Suite 250, Cambridge, MA 02141.
What is the IRS Employer Identification Number for Korro Bio, Inc.?
The IRS Employer Identification Number for Korro Bio, Inc. is 47-2324450.
What is the filing date of this Current Report (Form 8-K)?
The date of the report is November 4, 2024.
Filing Stats: 435 words · 2 min read · ~1 pages · Grade level 9.9 · Accepted 2024-11-04 07:30:08
Key Financial Figures
- $0.001 — ch registered Common stock, par value $0.001 per share KRRO The Nasdaq Capital M
Filing Documents
- krro-20241104.htm (8-K) — 44KB
- krro-ex99_1.htm (EX-99.1) — 35KB
- 0000950170-24-120282.txt ( ) — 239KB
- krro-20241104.xsd (EX-101.SCH) — 53KB
- krro-20241104_htm.xml (XML) — 5KB
01. Other Events
Item 8.01. Other Events. On November 4, 2024, Korro Bio, Inc. issued a press release announcing its first regulatory filing for KRRO-110. A copy of the press release is filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release of Korro Bio, Inc., dated November 4, 2024 104 Cover Page Interactive Data File (Embedded within the Inline XBRL Document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. KORRO BIO, INC. Date: November 4, 2024 By: /s/ Ram Aiyar Name: Ram Aiyar Title: President and Chief Executive Officer